Sonic Healthcare Ltd
ASX:SHL
Net Margin
Sonic Healthcare Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
12.7B AUD |
6%
|
|
| US |
|
Cigna Corp
NYSE:CI
|
88.5B USD |
2%
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
73.4B EUR |
2%
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
85.8B USD |
1%
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
28.1B EUR |
3%
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.7B EUR |
2%
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.5B USD |
6%
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
19.7B USD |
9%
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
13.9B EUR |
3%
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.9B USD |
7%
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
10.3B USD |
9%
|
Sonic Healthcare Ltd
Glance View
Sonic Healthcare Ltd. began its journey in 1987, carved from a niche of independent pathology practices in Australia. It swiftly evolved into a global player, embracing a model that combines local expertise with the strength of an international network. The heart of Sonic's operations lies in its robust diagnostic services. Its laboratories process millions of tests each year, ensuring timely and accurate results across a spectrum of medical diagnostics, including pathology, radiology, and general practice medicine. This core service is augmented by state-of-the-art technology and a commitment to quality care, which has earned Sonic a reputation for reliability and excellence in the healthcare sector. Financially, Sonic Healthcare thrives on a business model that capitalizes on high volume and steady demand for medical diagnostic services. The company generates revenue through contracts with hospitals, clinics, and governments, providing essential health services that are non-discretionary and resilient, even in economic downturns. Growth is driven by strategic acquisitions and partnerships, which expand its footprint across regions like North America and Europe, ensuring a stream of diversified income. As healthcare spending continues to rise globally, Sonic Healthcare's business model remains well-positioned to leverage its international presence and expertise in diagnostic excellence, fueling sustainable growth and shareholder value over the long term.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Sonic Healthcare Ltd's most recent financial statements, the company has Net Margin of 5.9%.
You don't have any saved screeners yet